With FDA Approval of Pfizer Vaccine, These Select ETFs May Perform Well

from Zacks.com September 23, 2021

The resurging cases brought on by the delta variant have frightened investors as they fear that implementation of a possible new lockdown may hurt the global economic recovery achieved thus far, reports Zacks.

However, considering the current market development with the FDA granting the first full U.S. government approval to the Pfizer (PFE) vaccine, investors’ confidence has been restored, for now. With the FDA’s full approval of the Pfizer vaccine, according to CNBC, three in 10 unvaccinated adults are now more likely to get the jab.

Against this backdrop, the article examines various ETFs that appear well-poised to gain based on the news. Towards the top of their list is the U.S. Global Jets ETF (JETS).

The U.S. Global Jets ETF provides investors access to the global airline industry, including airline operators and manufacturers from across the world. Although this industry has seen some ups and downs over the past two years, the airline industry overall has been gradually recovering to pre-pandemic levels.

You can find the full article on Zacks.com.

Learn more about the JETS ETF by clicking the button below!

Past performance does not guarantee future results. Please click here for standardized performance.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. The expense ratio is 0.60%.

U.S. Global Investors has authored and is responsible for the summary on this page. All opinions expressed and data provided are subject to change without notice. Opinions are not guaranteed and should not be considered investment advice.

The outbreak of the COVID-19 pandemic and the resulting actions to control or slow the spread has had a significant detrimental effect on the global and domestic economies, financial markets, and industries, including airlines. U.S. Global Investors continues to monitor the impact of COVID-19, but it is too early to determine the full impact this virus may have on commercial aviation. Should this emerging macro-economic risk continue for an extended period, there could be an adverse material financial impact to the U.S. Global Jets ETF.